The predictive accuracy of the DSS, IC50 and AA metrics was assessed in terms of their capability to distinguish the active dose-response curves from the inactive ones using the receiver operating characteristic (ROC) analyses; ROC curves evaluate the relative trade-off between true positive rate (sensitivity) and false positive rate (1 – specificity) of the metric when ordering the dose-response curves according to the increasing value of the response metric16 (link). The overall accuracy of each response metric was summarized using the area under the ROC curve (AUROC) measure; for an ideal metric, AUROC = 1, whereas a random metric obtains an AUROC = 0.5 on average. Statistical significance of an observed AUROC, when compared to random classifier, was assessed using the roc.area function in the R-package “verification”. Statistical significance of an observed AUROC difference between two response metrics was assessed using the “pROC” package with the De Long's test17 (link).
Identifying Exceptional Drug Responses
The predictive accuracy of the DSS, IC50 and AA metrics was assessed in terms of their capability to distinguish the active dose-response curves from the inactive ones using the receiver operating characteristic (ROC) analyses; ROC curves evaluate the relative trade-off between true positive rate (sensitivity) and false positive rate (1 – specificity) of the metric when ordering the dose-response curves according to the increasing value of the response metric16 (link). The overall accuracy of each response metric was summarized using the area under the ROC curve (AUROC) measure; for an ideal metric, AUROC = 1, whereas a random metric obtains an AUROC = 0.5 on average. Statistical significance of an observed AUROC, when compared to random classifier, was assessed using the roc.area function in the R-package “verification”. Statistical significance of an observed AUROC difference between two response metrics was assessed using the “pROC” package with the De Long's test17 (link).
Corresponding Organization :
Other organizations : Institute for Molecular Medicine Finland, University of Helsinki, Helsinki University Hospital
Protocol cited in 24 other protocols
Variable analysis
- Drug response distribution
- Sample skewness γ
- One-sided significance p-value
- Response levels between two pre-defined sample groups
- Predictive accuracy of the DSS, IC50 and AA metrics
- Area under the ROC curve (AUROC) measure
- No control variables explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!